Details

NameSymbolSector
ASTRAZENECA PHARMA INDIA LIMITEDASTRAZENPharmaceuticals
Open
8426
High
8979.5
Low
8205.5
Close
8314.5
Volume
257331
Exchange
nse
Time
14/08

Outlook

Score:  

2

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Astrazeneca Pharma India is  
High Wave
Estimated Stoploss of Astrazeneca Pharma India is ₹  
8979.5
Astrazeneca Pharma India has a  
Bearishℹ
 pattern. 
Formation of  
High Wave
 candle pattern indicates the trend direction of Astrazeneca Pharma India is  
Unpredictableℹ
. 

Trend

Astrazeneca Pharma India is in  
Downtrendℹ
. 
Price of Astrazeneca Pharma India is  
Downℹ
 by  

7.9

%. 
Target
Buy @ 

7820

Sell @ 

9221

Volume

The trades of Astrazeneca Pharma India have been in  
Immenseℹ
 volume. 
The volume trades for Astrazeneca Pharma India are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Astrazeneca Pharma India is  

Up

 by  

331.08

% 

Valuation

The current market price of Astrazeneca Pharma India is  
Overvaluedℹ

Financials

Balance
The balance sheet of Astrazeneca Pharma India is:  

Balanced

Cashflow
Astrazeneca Pharma India has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 30cr

. It is  
Upℹ
 by  

500

%. 

(*Mar 2025)

40.63% i.e. ₹ 65cr earned in operatingℹ
18.75% i.e. ₹ 30cr earned in investingℹ
40.63% i.e. ₹ 65cr spent in financingℹ
0% in otherℹ
Astrazeneca Pharma India has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 5cr

. It is  
Downℹ
 by  

90.2

%. 

(*Mar 2024)

29.35% i.e. ₹ 27cr earned in operatingℹ
22.83% i.e. ₹ 21cr earned in investingℹ
47.83% i.e. ₹ 44cr spent in financingℹ
0% in otherℹ
Income
The income of Astrazeneca Pharma India is  

₹ 537cr

 and  

Profit

 is :  

₹ 55cr

(*Jun 2025)

Astrazeneca Pharma India Profit is down by:  

5.17

% and Income is Up by:  

8.27

% 

(*Jun 2025)

The income of Astrazeneca Pharma India is  

₹ 496cr

 and  

Profit

 is :  

₹ 58cr

(*Mar 2025)

Astrazeneca Pharma India Profit is up by:  

93.33

% and Income is Up by:  

10.71

% 

(*Mar 2025)

The income of Astrazeneca Pharma India is  

₹ 448cr

 and  

Profit

 is :  

₹ 30cr

(*Dec 2024)

Astrazeneca Pharma India Profit is down by:  

21.05

% and Income is Up by:  

7.69

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.